Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries - and growing we look for talented people to grow our business, advance our science and contribute to our unique culture.
Translational Development at Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Investigational compounds are being studied for patients with hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), pancreatic cancer and lung cancer.
Translational Development is a department within the Research and Development organization that facilitates the transition of drug candidates from drug discovery through early- and late-stage clinical development. Early-stage translational development activities enable rational determination of dose-schedule and responsive patient populations, based on deep understanding of drug mechanism of action. Late-stage translational development activities build upon the early work, additionally exploring mechanisms of resistance, rational drug combinations and product differentiation. The late-stage translational development function is responsible for the development of translational strategies to support the development, and maximize the potential, of Celgene therapies post-clinical proof-of-concept, including registrations and life-cycle management.
Reporting to Senior Director, Translational Development & Diagnostics, the candidate will be part of the late stage lymphoma/CLL translational group based in Summit, NJ. The Associate Director role is a highly integrated role and will be responsible for developing, implementing and executing translational research strategies to support drug development programs in the disease areas of lymphoma/CLL while engaging and learning from counterpart activities in Multiple Myeloma and Myeloid disease groups. This individual will act as the translational lead on development teams, responsible for biomarker studies and analysis of patient data. The successful candidate will effectively interact with global project teams, clinical research physicians, clinical statisticians, computational biologists, contract research organizations, academic experts, and internal translational research scientists to deliver science that supports the development and access of medicines to patients in need.
Responsibilities will include, but are not limited to, the following:
· Member of cross-functional late-stage global project team, responsible for leading development and implementation of asset-specific translational strategies (e.g. mechanisms of drug efficacy, mechanisms of resistance, rational combinations, new indications, patient segmentations, and product differentiation)
·Develop research plans aligned with strategy
Responsible for the development and delivery of biomarker components of Celgene clinical trials, including protocol development, translational plans, and study conduct (assay development and implementation, ownership of quantity and quality of biosamples)
· Analyzes biomarkers for Celgene clinical studies by working with relevant functions and CROs; responsible for creating SOWs and interfacing with CRO for execution of services
Evaluates CROs for assay and data analysis capabilities
Develops constructive relationships across organization to achieve goals of the function and the business
Coordinate cross-functional activities through direct interaction with global project teams, clinical research physicians, clinicalstatisticians, clinical and translational operations, computational biologists, contract research organizations, academic experts, and internal translational scientists
· Authors study reports, biomarker components of clinical protocols, patent applications, regulatory submissions and peer-reviewed publications
· Develops translational network of academic experts and manages external collaborations; organizes regular meetings with KOLs and drives agendas
· Reviews external preclinical proposals and correlative study components of investigator initiated trials
· Champions Translational Development at project/franchise teams and governance/advisory meetings, leads translational development sub-team.
· Accountable for timelines and deliverables
Prioritizes risks and implements contingency plans
Communicates regularly; prepares and delivers presentations within the department and externally
·Contributes to the development of yearly budget
Provides leadership in creating a culture that demands scientific excellence, encourages innovative risk, strives for constant improvement, and is driven by a sense-of-urgency for patients
#LI-JB1 BIO-US PRIORITY
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.
Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.
Not ready to apply?Join Our Talent Network
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.